SANOFI-AVENTIS (EPA:SAN) | WebDisclosure

Basculer en Français

11026	Companies
241675	Keywords
170144	Articles
130116	Press releases

Home
Companies
SANOFI-AVENTIS

PRESS RELEASE

published on 03/27/2026 at 13:00, 5 months 23 days ago

Communiqué de presse : La formulation sous-cutanée de Sarclisa de Sanofi, administrée via un injecteur portable, est recommandée par le CHMP pour approbation dans l'UE dans le traitement du myélome multiple
Sanofi's Sarclisa subcutaneous formulation, recommended by CHMP for approval in the EU for multiple myeloma treatment. Positive results show efficacy & safety. First portable anticancer treatment with on-body injector

Sanofi Multiple Myeloma Sarclisa CHMP Subcutaneous
PRESS RELEASE

published on 03/27/2026 at 13:00, 5 months 23 days ago

Press Release: Sanofi’s Sarclisa subcutaneous formulation administered via on-body injector recommended for EU approval by the CHMP to treat multiple myeloma
Sanofi's Sarclisa subcutaneous formulation via on-body injector recommended for EU approval by CHMP for multiple myeloma treatment, offering innovative delivery. Final decision expected soon

Multiple Myeloma Sarclisa CHMP Recommendation On-Body Injector Subcutaneous Formulation
BRIEF

published on 03/24/2026 at 07:35, 5 months 26 days ago

Sanofi publie un aide-mémoire du premier trimestre 2026 pour soutenir l'analyse financière

Innovation Biopharma Sanofi Modélisation Financière Résultats Du T1 2026
BRIEF

published on 03/24/2026 at 07:35, 5 months 26 days ago

Sanofi Releases Q1 2026 Aide-Mémoire to Support Financial Analysis

Innovation Biopharma Sanofi Financial Modeling Q1 2026 Results
BRIEF

published on 03/24/2026 at 07:35, 5 months 26 days ago

Mise en ligne du guide financier Q1 2026 de Sanofi

Investisseurs Résultats Trimestriels Sanofi Document Financier Q1 2026
BRIEF

published on 03/24/2026 at 07:35, 5 months 26 days ago

Sanofi's Q1 2026 financial guide is now online

Investors Quarterly Results Sanofi Financial Document Q1 2026
PRESS RELEASE

published on 03/24/2026 at 07:30, 5 months 26 days ago

Press release: Availability of the Q1 2026 aide-mémoire
Sanofi announces availability of Q1 2026 aide-mémoire for financial modelling purposes. Details on non-comparable items, currency impact, and share count included. Results to be published on April 23, 2026

Sanofi Results Aide-mémoire Financial Modelling Q1 2026
PRESS RELEASE

published on 03/24/2026 at 07:30, 5 months 26 days ago

Communiqué de presse : Mise en ligne du document «Q1 2026 aide-mémoire »
Mise en ligne du document 'Q1 2026 aide-mémoire' par Sanofi pour faciliter la modélisation financière des résultats trimestriels avec des déclarations prospectives

Déclarations Prospectives Sanofi Modélisation Financière Aide-mémoire Q1 2026
BRIEF

published on 03/18/2026 at 07:05, 6 months 1 day ago

Sanofi : Désignation de thérapie innovante pour le venglustat aux États-Unis

FDA Sanofi Venglustat Maladie De Gaucher Découverte Médicale
BRIEF

published on 03/18/2026 at 07:05, 6 months 1 day ago

Sanofi's Venglustat Earns Breakthrough Therapy Designation for Gaucher Disease Type 3

FDA Sanofi Breakthrough Therapy Venglustat Gaucher Disease

Accesswire

Published on 09/19/2026 at 00:55, 1 day ago

Gossan Resources Announces Changes to Board and Management
Published on 09/18/2026 at 23:50, 1 day 1 hour ago

Mako Mining Announces Equity Incentive Grants
Published on 09/18/2026 at 22:00, 1 day 3 hours ago

Silver Tiger Announces Results of Annual and Special Meeting
Published on 09/18/2026 at 20:35, 1 day 5 hours ago

Only 11% of Marketers Expect Google Search to Be Their Customers' Main Starting Point in Two Years
Published on 09/18/2026 at 14:30, 1 day 11 hours ago

AIAI Holdings to Obtain a Controlling Position in Messier 42 Marketing Agreement

View all ACCESSWIRE

EQS Group

Published on 09/19/2026 at 16:40, 9 hours 8 minutes ago

2026 Cross-Strait (Kunshan) Mid-Autumn Lantern Festival Opens
Published on 09/19/2026 at 13:15, 12 hours 33 minutes ago

Eurobattery Minerals AB has received information regarding court judgment and criminal suspicion concerning the CEO
Published on 09/19/2026 at 07:30, 18 hours 18 minutes ago

Hong Kong sets out initiatives to secure long-term development of pillar industries
Published on 09/18/2026 at 18:45, 1 day 7 hours ago

Holding(s) in Company
Published on 09/18/2026 at 18:44, 1 day 7 hours ago

EQS-Adhoc: Enapter AG announces preliminary, unaudited figures for the first half of 2026 and restructures its US sales operations – one-off expense of EUR 17 million

Les Echos

Published on 09/18/2026 at 18:34, 1 day 7 hours ago

Disclosure of transactions in own shares from September 14 to September 18, 2026
Published on 09/18/2026 at 18:34, 1 day 7 hours ago

Déclaration hebdomadaire d'opérations effectuées du 14 au 18 septembre 2026
Published on 09/18/2026 at 18:10, 1 day 7 hours ago

Rapport semestriel 2026
Published on 09/18/2026 at 17:45, 1 day 8 hours ago

Press Release_Carrefour Bond_September 2026
Published on 09/18/2026 at 17:45, 1 day 8 hours ago

Communiqué de presse_Carrefour Bond_Septembre 2026

View all LES ECHOS COMFI WIRE